Sponsor

Haisco Pharmaceutical Group Co., Ltd.

Clinical research sponsor

Published trials20
Recruiting shown3
Roles1
SourceClinicalTrials.gov

Clinical trials

20 shown
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPDNCT07583849 · lead sponsor · 2026-05-24
RECRUITING
Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT07140328 · lead sponsor · 2025-04-24
RECRUITING
Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate CancerNCT07007910 · lead sponsor · 2024-12-18
RECRUITING
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPDNCT07658339 · lead sponsor · 2026-07-11
NOT_YET_RECRUITING
Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPDNCT07634367 · lead sponsor · 2026-07-10
NOT_YET_RECRUITING
HSK41959 With Standard Therapy in Solid Tumors With MTAP DeletionNCT07699757 · lead sponsor · 2026-07-01
NOT_YET_RECRUITING
Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPDNCT07425210 · lead sponsor · 2026-03-01
NOT_YET_RECRUITING
A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 DiabetesNCT07122102 · lead sponsor · 2025-10-01
NOT_YET_RECRUITING
Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT07108699 · lead sponsor · 2025-08-13
ACTIVE_NOT_RECRUITING
A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD PatientsNCT07331402 · lead sponsor · 2025-07-28
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus HypersecretionNCT06820749 · lead sponsor · 2024-12-10
ENROLLING_BY_INVITATION
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial AsthmaNCT06637254 · lead sponsor · 2024-10-22
ENROLLING_BY_INVITATION
A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes PatientsNCT06703268 · lead sponsor · 2024-01-15
COMPLETED
A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPDNCT06643078 · lead sponsor · 2023-12-11
COMPLETED
A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPDNCT06619210 · lead sponsor · 2022-01-12
COMPLETED
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride TabletsNCT04841720 · lead sponsor · 2021-04-01
UNKNOWN
HSK7653 in Chinese Patients with Impaired Glucose ToleranceNCT04727580 · lead sponsor · 2021-03-29
COMPLETED
A Study to Evaluate the DDI of HSK7653 With MetforminNCT06084156 · lead sponsor · 2019-08-10
COMPLETED
Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DMNCT06059326 · lead sponsor · 2019-01-22
COMPLETED
Single Escalating Dose Study Of HSK7653 In Healthy SubjectsNCT05983289 · lead sponsor · 2018-05-08
COMPLETED

Sponsor roles

lead sponsor20

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.